Follicular lymphoma trials in France
24 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1RecruitingTrial-stage medicine
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Lille, Paris
- Age
- 18 years and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328EU 2025-524180-20-00Registry updated 2026-11-04
Phase 1RecruitingTrial-stage medicine
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Nantes, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843EU 2025-523601-16-00Registry updated 2026-11-04
Phase 1RecruitingTrial-stage medicine
A Study of ARC-02 in B-cell NHL
- Where
- Creteil Cedex, Lille, Nantes, Pierre-Bénite, Villejuif Cedex
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606EU 2026-525606-35-00Registry updated 2026-11-02
Phase 1/2RecruitingTrial-stage medicine
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Clermont-Ferrand, Dijon, Montpellier Cedex 5, Nice, Paris
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772EU 2025-523005-15-00Registry updated 2026-10-29
Phase 2/3RecruitingTrial-stage medicine
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Where
- Dijon, Tours Cedex 9
- Age
- 18 years and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07634471EU 2025-522777-10-00Registry updated 2026-10-26
Phase 3RecruitingTrial-stage medicine
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Bayonne, Creteil Cedex, Grenoble Cedex 9, Lille Cedex, Montpellier Cedex 5, Rennes Cedex 9, Saint-Cloud, Vandoeuvre Les Nancy
- Age
- 18 years to 130 years
- People
- 1,018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595EU 2023-510098-33-01Registry updated 2026-10-21
Phase 2RecruitingTrial-stage medicine
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Montpellier Cedex 5, Paris Cedex 10, Pierre-Bénite, Rouen Cedex
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793EU 2023-505789-27-00Registry updated 2026-10-14
Phase 2RecruitingTrial-stage medicine
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- Grenoble Cedex 9, Montpellier Cedex 5, Pessac, Rennes Cedex 9, Tours Cedex 9
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033EU 2024-516791-15-00Registry updated 2026-10-09
Phase 3RecruitingTrial-stage medicine
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Where
- Argenteuil Cedex, Avignon, Bobigny Cedex, Bordeaux Cedex, Chambéry, Lomme Cedex, Marseille, Montpellier Cedex 5, Nantes, Paris, Pessac, Rennes, Rouen, Saint-Cloud, Tours Cedex 9, Villejuif
- Age
- 18 years and over
- People
- 580 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06149286EU 2022-503092-28-00Registry updated 2026-10-07
Phase 3RecruitingTrial-stage medicine
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Where
- Angers, Argenteuil, Marseille, Nantes, Paris, Poitiers, Rennes, Strasbourg, Tours, Villejuif
- Age
- 18 years and over
- People
- 822 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091254EU 2022-502660-20-00Registry updated 2026-10-06
Phase 1/2RecruitingTrial-stage medicine
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Bordeaux, ClermontFerrand, Créteil, Lille, Lyon, Marseille, Montpellier, Paris, Rouen
- Age
- 18 years and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716EU 2022-502157-33-00Registry updated 2026-10-05
Phase 1/2RecruitingTrial-stage medicine
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Pessac, Villejuif
- Age
- 18 years and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250Registry updated 2026-09-30
Phase 2Not yet recruitingTrial-stage medicine
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
- Where
- Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Toulouse, Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 55
- Run by
- The Lymphoma Academic Research Organisation
See details and how to joinNCT07814001Registry updated 2026-09-10
Phase 1RecruitingTrial-stage medicine
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
- Where
- Bordeaux, Marseille, Nantes
- Age
- 18 years and over
- People
- 85 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116EU 2024-516869-36-00Registry updated 2026-08-13
Phase 1RecruitingTrial-stage medicine
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Angers, Bobigny, Nantes, Pessac, Poitiers, Saint-Cloud, Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022EU 2023-510541-25-00Registry updated 2026-07-02
No phaseRecruitingResearch participation
Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 years and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848Registry updated 2026-06-18
Phase 2RecruitingTrial-stage medicine
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Creteil Cedex, Lille Cedex, Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 18 years to 70 years
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866EU 2023-506270-13-00Registry updated 2026-06-10
No phaseRecruitingResearch participation
Long-term Ovarian Fertility in Patients Treated for Lymphoma.
- Where
- Lille
- Age
- 18 years to 45 years
- People
- 270
- Run by
- University Hospital, Lille
See details and how to joinNCT05616325Registry updated 2026-05-22
Phase 3RecruitingTrial-stage medicine
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Where
- Lille Cedex, Montpellier, Nantes, Paris, Pessac, Pierre-Bénite, Saint-Cloud, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Celgene
See details and how to joinNCT06911502EU 2024-519152-82-00Registry updated 2026-05-20
Phase 4RecruitingResearch participation
ETCABio - Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 years and over
- People
- 140
- Run by
- Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00EU 2024-519812-15-00Registry updated 2026-03-19
Phase 1RecruitingTrial-stage medicine
Study of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Creteil Cedex, Villejuif
- Age
- 18 years and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019EU 2023-505204-34-00Registry updated 2026-02-13
No phaseRecruitingResearch participation
Hypnosis: a Path to Appeasement
- Where
- Lyon
- Age
- 18 years and over
- People
- 50
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT05942885Registry updated 2025-09-11
No phaseRecruitingResearch participation
MOLyF : Bone Marrow and Follicular Lymphoma
- Where
- Rennes
- Age
- 18 years and over
- People
- 200
- Run by
- Rennes University Hospital
See details and how to joinNCT06608147Registry updated 2024-12-10
No phaseRecruitingResearch participation
REal World Data in LYmphoma and Survival in Adults
- Where
- Arras, Besançon, Bordeaux, Bourgoin, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Dunkirk, Grenoble, La Roche-sur-Yon, La Tronche, Le Mans, Libourne, Lille, Limoges, Lyon, Montpellier, Mulhouse, Nantes, Niort, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Roubaix, Rouen, Saint-Brieuc, Saint-Cloud, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Vannes
- Age
- 18 years and over
- People
- 6,000
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT03869619Registry updated 2021-06-28
All Follicular lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.